Sproutly Canada announced the launch of its common stock on the Canadian Securities Exchange (CSE) under the ticker symbol “SPR.”
Sproutly Canada (CSE:SPR) announced the launch of its common stock on the Canadian Securities Exchange (CSE) under the ticker symbol “SPR.”
As quoted in the press release:
Sproutly is an ACMPR Licensed Producer of cannabis that strives to meet the evolving needs of cannabis consumers across Canada. Its mission is to become a vertically integrated cannabis consumer products company, bringing together best-in-class cultivation, secured distribution solutions, and advanced technologies to redefine the cannabis industry. Sproutly currently owns and operates a 16,600 [square feet] production facility located centrally in the GTA utilizing state-of-the-art production technology and methods designed to best-in-class standards.
The Company previously announced signing of letters of intent to acquire 1) Infusion Biosciences Canada Inc, a biotech company possessing the rights to Infusion Biosciences Inc.’s (“Infusion Biosciences”) APP Technology for specific jurisdictions; and 2) SSM Partners Inc., a management company engaged in the commercialization of products and formulation services for APP Technology in specific jurisdictions, (together referred to as “Infusion Biosciences Canada” or the “Proposed Acquisition”). The transaction is expected to be completed in July.